Rejection of the kidney allograft.

This review gives an account of our current understanding of the mechanisms of rejection of renal allografts. New immunosuppressive agents show promise, but graft survival beyond 5 years has not improved substantially.

[1]  T. Strom,et al.  TIM-1: A New Player in Transplant Immunity , 2009, Transplantation.

[2]  M. Sarwal,et al.  Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. , 2003, The New England journal of medicine.

[3]  R. Vaughan,et al.  Influence of donor C3 allotype on late renal-transplantation outcome. , 2006, The New England journal of medicine.

[4]  B. Aizenstein,et al.  Noninvasive Detection of Acute and Chronic Injuries in Human Renal Transplant by Elevation of Multiple Cytokines/Chemokines in Urine , 2009, Transplantation.

[5]  F. Tedla Costimulation Blockade With Belatacept in Renal Transplantation , 2006 .

[6]  M. Suthanthiran,et al.  Noninvasive Prediction of Organ Graft Rejection and Outcome Using Gene Expression Patterns , 2008, Transplantation.

[7]  S Takemoto,et al.  High survival rates of kidney transplants from spousal and living unrelated donors. , 1995, The New England journal of medicine.

[8]  K. Olthoff,et al.  The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection. , 1991, Transplantation.

[9]  V. Sánchez Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation , 2010 .

[10]  R. Colvin Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. , 2007, Journal of the American Society of Nephrology : JASN.

[11]  M. Suthanthiran,et al.  Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. , 2001, The New England journal of medicine.

[12]  R. Bleackley,et al.  Cytotoxic T lymphocytes: all roads lead to death , 2002, Nature Reviews Immunology.

[13]  P. Halloran,et al.  Diagnosing Rejection in Renal Transplants: A Comparison of Molecular‐ and Histopathology‐Based Approaches , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  A. S. Wiener,et al.  Transplantation , 1963 .

[15]  D. Kreisel,et al.  Mouse Vascular Endothelium Activates CD8+ T Lymphocytes in a B7-Dependent Fashion1 , 2002, The Journal of Immunology.

[16]  S. Sacks,et al.  Local synthesis of complement component C3 regulates acute renal transplant rejection , 2002, Nature Medicine.

[17]  J. Schold,et al.  Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  E. Reed,et al.  Assessing Relative Risks of Infection and Rejection: A Meta-analysis using an Immune Function Assay , 2006, Transplantation.

[19]  J. Schold,et al.  Value of Posttransplant Antibody Tests in the Evaluation of Patients with Renal Graft Dysfunction , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  M. Stegall,et al.  Deciphering antibody-mediated rejection: new insights into mechanisms and treatment , 2010, Current Opinion in Organ Transplantation.

[21]  P. Morris Transplantation--a medical miracle of the 20th century. , 2004, The New England journal of medicine.

[22]  K. Wood,et al.  Regulatory lymphocytes: Regulatory T cells in transplantation tolerance , 2003, Nature Reviews Immunology.

[23]  X. Li,et al.  Costimulatory pathways in transplantation: challenges and new developments , 2009, Immunological reviews.

[24]  D. Bishop,et al.  Contrasting Alloreactive CD4+ and CD8+ T Cells: There's More to It Than MHC Restriction , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  Fadi G Lakkis,et al.  Lymphoid Neogenesis in Murine Cardiac Allografts Undergoing Chronic Rejection , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[26]  S. Tullius,et al.  Impact of innate and adaptive immunity on rejection and tolerance. , 2008, Transplantation.

[27]  A. Abbas,et al.  Control of CD4+ T‐cell memory by cytokines and costimulators , 2006, Immunological reviews.

[28]  P. Morris,et al.  Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection , 1990, The Journal of experimental medicine.

[29]  R. Stratta,et al.  Optimal use of older donors and recipients in kidney transplantation. , 2006, Surgery.

[30]  A. Kirk,et al.  Functionally Significant Renal Allograft Rejection Is Defined by Transcriptional Criteria , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[31]  P. Allen,et al.  Processing and presentation of self and foreign antigens by the renal proximal tubule. , 1992, Journal of immunology.

[32]  M. Sayegh,et al.  Role of indirect allorecognition in experimental late acute rejection. , 1997, Transplantation.

[33]  L C Racusen,et al.  Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[34]  Philip F Halloran,et al.  Immunosuppressive drugs for kidney transplantation. , 2004, The New England journal of medicine.

[35]  G. Dubyak,et al.  Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. , 2008, Immunity.

[36]  P. Stastny,et al.  Antibodies against MICA antigens and kidney-transplant rejection. , 2007, The New England journal of medicine.

[37]  G. Einecked,et al.  Banff 07 Classification of Renal Allograft Pathology : Updates and Future Directions , 2008 .

[38]  K. Wood,et al.  Interleukin-23 and TH17 cells in transplantation immunity: does 23+17 equal rejection? , 2007, Transplantation.

[39]  E. Palmer,et al.  Quantifying the Frequency of Alloreactive T Cells In Vivo: New Answers to an Old Question1 , 2001, The Journal of Immunology.

[40]  M. Goldman,et al.  The multiple facets of toll-like receptors in transplantation biology. , 2008, Transplantation.

[41]  J. Skepper,et al.  Expression of Tumor Necrosis Factor Receptors in Normal Kidney and Rejecting Renal Transplants , 2001, Laboratory Investigation.

[42]  L. K. Ely,et al.  T-cells behaving badly: structural insights into alloreactivity and autoimmunity. , 2008, Current opinion in immunology.

[43]  C. Alpers,et al.  Expression of chemokines and chemokine receptors during human renal transplant rejection. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[44]  S. Sumitran-Holgersson,et al.  Relevance of MICA and other non-HLA antibodies in clinical transplantation. , 2008, Current opinion in immunology.

[45]  J. Kirby,et al.  Post‐Transplant Renal Tubulitis: The Recruitment, Differentiation and Persistence of Intra‐Epithelial T Cells , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[46]  G. Danovitch,et al.  Allocation of deceased donor kidneys: past, present, and future. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[47]  A. Chandraker,et al.  Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. , 2005, The New England journal of medicine.

[48]  R. Colvin,et al.  Kidney transplantation: mechanisms of rejection and acceptance. , 2008, Annual review of pathology.

[49]  L. Gardner,et al.  Leukocyte extravasation: chemokine transport and presentation by the endothelium. , 2002, Blood.

[50]  P. Nickel,et al.  Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients. , 2008, Journal of the American Society of Nephrology : JASN.

[51]  M. Pescovitz,et al.  A Phase I/II Randomized Open‐Label Multicenter Trial of Efalizumab, a Humanized Anti‐CD11a, Anti‐LFA‐1 in Renal Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[52]  J. Stockman Messenger RNA for FOXP3 in the Urine of Renal-Allograft Recipients , 2007 .

[53]  A. Morley,et al.  Renal allograft rejection: beta-chemokine involvement in the development of tubulitis. , 2000, Transplantation.

[54]  D. Segev,et al.  The Use of Antibody to Complement Protein C5 for Salvage Treatment of Severe Antibody‐Mediated Rejection , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[55]  M. Sayegh,et al.  Transplantation 50 years later--progress, challenges, and promises. , 2004, The New England journal of medicine.

[56]  Y. Zhai,et al.  Th1 and Th2 cytokines in organ transplantation: paradigm lost? , 1999, Critical reviews in immunology.

[57]  J. Cyster,et al.  FTY720: Sphingosine 1‐Phosphate Receptor‐1 in the Control of Lymphocyte Egress and Endothelial Barrier Function , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[58]  Raghu Kalluri,et al.  EMT: when epithelial cells decide to become mesenchymal-like cells. , 2009, The Journal of clinical investigation.

[59]  M. Pescovitz Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[60]  H. Gudmundsdottir,et al.  A Closer Look at Homeostatic Proliferation of CD4+ T Cells: Costimulatory Requirements and Role in Memory Formation1 , 2001, The Journal of Immunology.

[61]  J. Chapman,et al.  The natural history of chronic allograft nephropathy. , 2003, The New England journal of medicine.

[62]  V. Kuchroo,et al.  Interleukin-17 and type 17 helper T cells. , 2009, The New England journal of medicine.

[63]  J. Platt,et al.  Accommodation in organ transplantation , 2008, Current opinion in organ transplantation.

[64]  P. Terasaki Humoral Theory of Transplantation , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[65]  P. Heeger,et al.  Graft-derived complement as a mediator of transplant injury. , 2007, Current opinion in immunology.

[66]  A. Lichtman,et al.  Interactions between T lymphocytes and endothelial cells in allograft rejection. , 1998, Current opinion in immunology.

[67]  E. Ellis,et al.  Acute rejection-associated tubular basement membrane defects and chronic allograft nephropathy. , 2000, Kidney international.

[68]  G. Jhangri,et al.  FOXP3 Expression in Human Kidney Transplant Biopsies Is Associated with Rejection and Time Post Transplant but Not with Favorable Outcomes , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[69]  R. Atkins,et al.  The Role of Macrophages in Allograft Rejection , 2005, Transplantation.

[70]  J. Ritz,et al.  Minor Histocompatibility Antigen DBY Elicits a Coordinated B and T Cell Response after Allogeneic Stem Cell Transplantation , 2004, The Journal of experimental medicine.

[71]  H. Auchincloss,et al.  Involvement of the direct and indirect pathways of allorecognition in tolerance induction. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[72]  C. Larsen,et al.  Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology. , 2001, Transplantation.

[73]  R. Lechler,et al.  New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance. , 2004, Current opinion in immunology.

[74]  C. Zeng,et al.  Late and early C4d-positive acute rejection: different clinico-histopathological subentities in renal transplantation. , 2006, Kidney international.

[75]  P. Parham,et al.  Mini‐review: Defense strategies and immunity‐related genes , 2004, European journal of immunology.